Skip to content

Pressure-dependent Changes in Hematocrit and Plasma Volume During Anesthesia

Pressure-dependent Changes in Hematocrit and Plasma Volume During Anesthesia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02412189
Enrollment
24
Registered
2015-04-09
Start date
2014-02-28
Completion date
2015-05-31
Last updated
2015-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Blood Pressure, Hematocrit Change

Keywords

Anesthesia, Blood pressure, Plasma volume, Vasopressor agents, Continuous noninvasive hemoglobin measurement, Coronary artery bypass

Brief summary

The arterial blood pressure affects the ratio between filtration and reabsorption of fluids in the circulating blood volume and thereby the hematocrit. During induction of anesthesia blood pressure, hemoglobin level and hematocrit decreases. The aim of the study is to evaluate weather a maintained blood pressure with norepinephrine during anesthesia induction reduces the decrease in hematocrit.

Detailed description

24 patients scheduled for coronary artery bypass surgery will be included and randomized to receive either norepinephrine in the dose needed to maintain pre-anesthesia blood pressure or to a control group and receive norepinephrine only if mean arterial pressure decreases below 60 mmHg. Arterial blood gas will be analysed every ten minutes. Equal anesthesia in both groups will be monitored. No fluids will be infused. Noninvasive continuous hemoglobin measurement (SpHb) will be measured.

Interventions

Norepinephrine therapy to maintain preanesthesia blood pressure

DRUGNorepinephrine

Norepinephrine therapy to maintain preanesthesia blood pressure

Sponsors

Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elective coronary artery surgery patients

Exclusion criteria

* Age under 18 years * untreated hypertension * a reduced left ventricular systolic ejection fraction of 45 % or less * diabetes mellitus * former stroke and/or a known carotid artery stenosis.

Design outcomes

Primary

MeasureTime frame
The magnitude and dynamics of the decrease in hematocrit during anesthesia induction70 minutes from anesthesia induction

Secondary

MeasureTime frameDescription
Reduced hematocrit decrease by vasopressor infusion maintained blood pressure70 minutes from anesthesia inductionTo assess if the decrease in hematocrit can be reduced, by maintaining the blood pressure with vasopressor infusion

Other

MeasureTime frameDescription
Accuracy of continuous non-invasive hemoglobin monitoring (SpHb) to invasive Hb levels70 minutes from anesthesia inductionTo evaluate if changes in invasive measured Hb levels, can be measured by continuous non-invasive hemoglobin monitoring (SpHb).

Countries

Sweden

Contacts

Primary ContactTor Damén, MD
tor.damen@vgregion.se+46313427873
Backup ContactAndreas Nygren, MD
andreas.nygren@aniv.gu.se+46313427444

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026